Dr. Aniruddha Ray, assistant professor of physics at The University of Toledo, is one of 55 early-career researchers nationwide chosen by the Research Corporation for Science Advancement as a fellow for its new initiative to advance bioimaging.
Fellows in the new Scialog initiative include physicists, chemists, engineers and biologists who will work together for three years to address challenges involved in enhancing high-resolution imaging of tissues to support basic science and the treatment of disease.
Ray
“I am extremely grateful to be chosen for this prestigious fellowship,” Ray said. “This bioimaging program supported by the Research Corporation for Science Advancement, Chan Zuckerberg Initiative and Frederick Gardner Cottrell Foundation will provide an excellent opportunity for me to network with a unique group of young scientists in this field.”
Scialog is short for “science” and “dialogue.” Created in 2010 by the Research Corporation for Science Advancement, the Scialog format creates communities of early-career scholars selected from multiple disciplines and institutions across the U.S. and Canada. Guided by a group of senior facilitators, participating scientists discuss challenges and bottlenecks, build community around visionary goals for developing and deploying these technologies and seek collaborators for cutting-edge research projects.
“This is a wonderful chance for Dr. Ray to be part of an excellent group of rising young faculty members across the nation,” said Dr. Karen Bjorkman, provost and executive vice president for academic affairs. “The diverse group of scientists is made up of potential collaborators for his work on cutting-edge approaches in the field of optical imaging.”
Ray’s research laboratory develops imaging and biosensing platforms based on nanotechnology and photonics for solving complex problems in biomedical research, such as understanding the pathophysiology of diseases and studying the interaction of drugs at sub-cellular level.
These platforms, which are both cost-effective and portable, aid personalized medicine by translating biomedical research from the laboratory to the point of care.
The first meeting of the fellows in this Scialog series will take place virtually in May.
At each conference, participants form multidisciplinary teams to design research projects, which they pitch to a committee of leading scientists who have facilitated discussions throughout the meeting. The committee then recommends seed funding to catalyze the most promising of those team projects, based primarily on the potential for high-impact results.
For a full list of the fellows, visit the website for the Research Corporation for Science Advancement.
